Patents by Inventor Nidal Muvarak

Nidal Muvarak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapy regimen and methods to sensitize cancer cells treated with epigenetic therapy to PARP inhibitors in lung cancer
    Patent number: 10105383
    Abstract: The presently disclosed subject matter provides methods to treat cancer cells using low doses of DNA demethylating agents and poly ADP ribose polymerase (PARP) inhibitors. Methods also are provided for sensitizing a cell to a PARP inhibitor.
    Type: Grant
    Filed: September 1, 2016
    Date of Patent: October 23, 2018
    Assignees: UNIVERSITY OF MARYLAND, BALTIMORE, THE JOHNS HOPKINS UNIVERSITY
    Inventors: Feyruz Rassool, Stephen Baylin, Carine Robert, Khadiza Chowdhury, Nidal Muvarak
  • Therapy regimen and methods to sensitize cancer cells treated with epigenetic therapy to PARP inhibitors in ovarian cancer
    Patent number: 10105382
    Abstract: The presently disclosed subject matter provides methods to treat cancer cells using low doses of DNA demethylating agents and poly ADP ribose polymerase (PARP) inhibitors. Methods also are provided for sensitizing a cell to a PARP inhibitor.
    Type: Grant
    Filed: September 1, 2016
    Date of Patent: October 23, 2018
    Assignees: UNIVERSITY OF MARYLAND, BALTIMORE, THE JOHNS HOPKINS UNIVERSITY
    Inventors: Feyruz Rassool, Stephen Baylin, Carine Robert, Khadiza Chowdhury, Nidal Muvarak
  • THERAPY REGIMEN AND METHODS TO SENSITIZE CANCER CELLS TREATED WITH EPIGENETIC THERAPY TO PARP INHIBITORS IN LUNG CANCER
    Publication number: 20160367582
    Abstract: The presently disclosed subject matter provides methods to treat cancer cells using low doses of DNA demethylating agents and poly ADP ribose polymerase (PARP) inhibitors. Methods also are provided for sensitizing a cell to a PARP inhibitor.
    Type: Application
    Filed: September 1, 2016
    Publication date: December 22, 2016
    Applicants: THE JOHNS HOPKINS UNIVERSITY, UNIVERSITY OF MARYLAND, BALTIMORE
    Inventors: Feyruz RASSOOL, Stephen BAYLIN, Carine ROBERT, Khadiza Chowdhury, Nidal Muvarak
  • THERAPY REGIMEN AND METHODS TO SENSITIZE CANCER CELLS TREATED WITH EPIGENETIC THERAPY TO PARP INHIBITORS IN OVARIAN CANCER
    Publication number: 20160367581
    Abstract: The presently disclosed subject matter provides methods to treat cancer cells using low doses of DNA demethylating agents and poly ADP ribose polymerase (PARP) inhibitors. Methods also are provided for sensitizing a cell to a PARP inhibitor.
    Type: Application
    Filed: September 1, 2016
    Publication date: December 22, 2016
    Applicants: THE JOHNS HOPKINS UNIVERSITY, UNIVERSITY OF MARYLAND, BALTIMORE
    Inventors: Feyruz RASSOOL, Stephen BAYLIN, Carine ROBERT, Khadiza Chowdhury, Nidal Muvarak